| Interpro ID | IPR007110 |
| Name | Ig-like_dom |
| Description | Immunoglobulin-like domain |
| Cross References | PF13895, PS50835, SSF48726 |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
A1BG | alpha-1-B glycoprotein |
1 | P04217 | chr19: 58,345,178-58,353,499 |
ACAN | aggrecan |
176 | P16112 | chr15: 88,803,443-88,875,354 |
ADGRA3 | adhesion G protein-coupled receptor A3 |
166647 | Q8IWK6 | chr4: 22,345,071-22,516,054 |
ALCAM | activated leukocyte cell adhesion molecule |
214 | Q13740 | chr3: 105,366,909-105,576,900 |
AZGP1 | alpha-2-glycoprotein 1, zinc-binding |
563 | P25311 | chr7: 99,966,720-99,976,157 |
B2M | beta-2-microglobulin |
567 | P61769 | chr15: 44,711,477-44,718,877 |
BCAM | basal cell adhesion molecule (Lutheran blood group) |
4059 | P50895 | chr19: 44,809,059-44,821,420 |
BCAN | brevican |
63827 | Q96GW7 | chr1: 156,641,390-156,659,532 |
BSG | basigin (Ok blood group) |
682 | P35613 | chr19: 571,277-583,493 |
BTN2A1 | butyrophilin subfamily 2 member A1 |
11120 | Q7KYR7 | chr6: 26,457,904-26,476,621 |
BTN2A2 | butyrophilin subfamily 2 member A2 |
10385 | Q8WVV5 | chr6: 26,383,096-26,394,874 |
BTN3A2 | butyrophilin subfamily 3 member A2 |
11118 | P78410 | chr6: 26,365,159-26,378,320 |
BTN3A3 | butyrophilin subfamily 3 member A3 |
10384 | O00478 | chr6: 26,440,472-26,453,415 |
C10orf54 | chromosome 10 open reading frame 54 |
64115 | Q9H7M9 | chr10: 71,747,559-71,773,498 |
CADM1 | cell adhesion molecule 1 |
23705 | Q9BY67 | chr11: 115,169,218-115,504,957 |
CCDC141 | coiled-coil domain containing 141 |
285025 | Q6ZP82 | chr2: 178,830,269-179,050,086 |
CD1D | CD1d molecule |
912 | P15813 | chr1: 158,179,947-158,184,896 |
CD200 | CD200 molecule |
4345 | P41217 | chr3: 112,332,347-112,362,812 |
CD244 | CD244 molecule, natural killer cell receptor 2B4 |
51744 | Q9BZW8 | chr1: 160,830,160-160,862,855 |
CD276 | CD276 molecule |
80381 | Q5ZPR3 | chr15: 73,683,966-73,714,518 |
CD28 | CD28 molecule |
940 | P10747 | chr2: 203,706,475-203,738,912 |
CD33 | CD33 molecule |
945 | P20138 | chr19: 51,225,064-51,243,860 |
CD4 | CD4 molecule |
920 | P01730 | chr12: 6,786,858-6,820,808 |
CD47 | CD47 molecule |
961 | Q08722 | chr3: 108,043,298-108,091,025 |
CD48 | CD48 molecule |
962 | P09326 | chr1: 160,678,746-160,711,851 |
CD58 | CD58 molecule |
965 | P19256 | chr1: 116,514,535-116,571,039 |
CD83 | CD83 molecule |
9308 | Q01151 | chr6: 14,117,256-14,136,918 |
CEACAM21 | carcinoembryonic antigen-related cell adhesion molecule 21 |
90273 | Q3KPI0 | chr19: 41,549,518-41,586,844 |
CEACAM4 | carcinoembryonic antigen-related cell adhesion molecule 4 |
1089 | O75871 | chr19: 41,618,971-41,627,074 |
CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 |
1087 | Q14002 | chr19: 41,673,307-41,706,976 |
CHL1 | cell adhesion molecule L1-like |
10752 | O00533 | chr3: 196,596-409,417 |
CILP | cartilage intermediate layer protein |
8483 | O75339 | chr15: 65,194,758-65,211,488 |
CNTN1 | contactin 1 |
1272 | Q12860 | chr12: 40,692,442-41,072,418 |
CNTN3 | contactin 3 |
5067 | Q9P232 | chr3: 74,262,568-74,521,140 |
CNTN4 | contactin 4 |
152330 | Q8IWV2 | chr3: 2,098,813-3,057,956 |
CSF1R | colony stimulating factor 1 receptor |
1436 | P07333 | chr5: 150,053,291-150,113,372 |
CSF3R | colony stimulating factor 3 receptor |
1441 | Q99062 | chr1: 36,466,043-36,483,278 |
CXADR | coxsackie virus and adenovirus receptor |
1525 | P78310 | chr21: 17,512,382-17,593,579 |
ERMAP | erythroblast membrane-associated protein (Scianna blood group) |
114625 | Q96PL5 | chr1: 42,817,124-42,844,989 |
F11R | F11 receptor |
50848 | Q9Y624 | chr1: 160,995,211-161,021,348 |
FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) |
2209 | P12314 | chr1: 149,782,671-149,792,518 |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) |
2210 | Q92637 | chr1: 121,087,345-121,096,310 |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) |
2212 | P12318 | chr1: 161,505,430-161,524,013 |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 | P31994 | chr1: 161,663,147-161,678,654 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
2215 | O75015 | chr1: 161,623,196-161,631,963 |
FCMR | Fc fragment of IgM receptor |
9214 | O60667 | chr1: 206,904,386-206,923,247 |
FCRL1 | Fc receptor-like 1 |
115350 | Q96LA6 | chr1: 157,794,403-157,820,105 |
FGFR1 | fibroblast growth factor receptor 1 |
2260 | P11362 | chr8: 38,411,138-38,468,834 |
FGFR2 | fibroblast growth factor receptor 2 |
2263 | P21802 | chr10: 121,478,334-121,598,458 |
FLT4 | fms-related tyrosine kinase 4 |
2324 | P35916 | chr5: 180,601,506-180,649,624 |
HAPLN1 | hyaluronan and proteoglycan link protein 1 |
1404 | P10915 | chr5: 83,637,805-83,721,613 |
HFE | hemochromatosis |
3077 | Q30201 | chr6: 26,087,281-26,098,343 |
HLA-A | major histocompatibility complex, class I, A |
3105 | P30443 | chr6: 29,941,260-29,945,884 |
HLA-B | major histocompatibility complex, class I, B |
3106 | P01889 | chr6: 31,269,491-31,357,188 |
HLA-C | major histocompatibility complex, class I, C |
3107 | P30499 | chr6: 31,268,749-31,272,130 |
HLA-DMA | major histocompatibility complex, class II, DM alpha |
3108 | P28067 | chr6: 32,948,613-32,969,094 |
HLA-DMB | major histocompatibility complex, class II, DM beta |
3109 | P28068 | chr6: 32,934,629-32,941,070 |
HLA-DOB | major histocompatibility complex, class II, DO beta |
3112 | P13765 | chr6: 32,812,763-32,817,048 |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 |
3113 | P20036 | chr6: 33,064,569-33,080,775 |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 |
3117 | P01909 | chr6: 32,628,179-32,647,062 |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 |
3118 | P01906 | chr6: 32,741,342-32,747,215 |
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 |
3119 | P01920 | chr6: 32,659,467-32,668,383 |
HLA-DRA | major histocompatibility complex, class II, DR alpha |
3122 | P01903 | chr6: 32,439,842-32,445,046 |
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
3123 | P04229 | chr6: 32,578,769-32,589,848 |
HLA-DRB3 | major histocompatibility complex, class II, DR beta 3 |
3125 | P79483 | chr6: 32,444,128-32,457,245 |
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 |
3126 | P13762 | chr6: 32,542,598-32,557,561 |
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 |
3127 | Q30154 | chr6: 32,517,343-32,530,287 |
HLA-E | major histocompatibility complex, class I, E |
3133 | P13747 | chr6: 30,489,467-30,494,205 |
HLA-F | major histocompatibility complex, class I, F |
3134 | P30511 | chr6: 29,722,775-29,738,528 |
HLA-G | major histocompatibility complex, class I, G |
3135 | P17693 | chr6: 29,826,967-29,831,125 |
HLA-H | major histocompatibility complex, class I, H (pseudogene) |
3136 | P01893 | chr6: 29,879,053-29,881,769 |
HSPG2 | heparan sulfate proteoglycan 2 |
3339 | P98160 | chr1: 21,822,245-21,937,297 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
IGDCC4 | immunoglobulin superfamily, DCC subclass, member 4 |
57722 | Q8TDY8 | chr15: 65,381,464-65,423,072 |
IGFBP7 | insulin like growth factor binding protein 7 |
3490 | Q16270 | chr4: 57,030,773-57,110,385 |
IGHG1 | immunoglobulin heavy constant gamma 1 (G1m marker) |
3500 | P01857 | chr14: 105,736,343-105,743,071 |
IGHM | immunoglobulin heavy constant mu |
3507 | P01871 | chr14: 105,851,708-105,856,218 |
IGKC | immunoglobulin kappa constant |
3514 | P01834 | chr2: 88,857,161-88,857,683 |
IGLL5 | immunoglobulin lambda-like polypeptide 5 |
100423062 | B9A064 | chr22: 22,887,780-22,896,107 |
IGSF11 | immunoglobulin superfamily member 11 |
152404 | Q5DX21 | chr3: 118,900,557-119,146,068 |
IGSF9B | immunoglobulin superfamily member 9B |
22997 | Q9UPX0 | chr11: 133,908,564-133,956,985 |
IL18R1 | interleukin 18 receptor 1 |
8809 | Q13478 | chr2: 102,311,529-102,398,775 |
IL1R1 | interleukin 1 receptor, type I |
3554 | P14778 | chr2: 102,064,544-102,179,874 |
IL1R2 | interleukin 1 receptor, type II |
7850 | P27930 | chr2: 101,991,844-102,028,544 |
IL1RAP | interleukin 1 receptor accessory protein |
3556 | Q9NPH3 | chr3: 190,514,051-190,659,750 |
IL1RL1 | interleukin 1 receptor-like 1 |
9173 | Q01638 | chr2: 102,311,502-102,352,037 |
IL6R | interleukin 6 receptor |
3570 | P08887 | chr1: 154,405,193-154,469,450 |
ILDR2 | immunoglobulin-like domain containing receptor 2 |
387597 | Q71H61 | chr1: 166,895,711-166,975,482 |
ISLR | immunoglobulin superfamily containing leucine-rich repeat |
3671 | O14498 | chr15: 74,173,671-74,176,872 |
JAM2 | junctional adhesion molecule 2 |
58494 | P57087 | chr21: 25,639,272-25,717,562 |
JAM3 | junctional adhesion molecule 3 |
83700 | Q9BX67 | chr11: 134,068,925-134,152,001 |
KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 |
81621 | Q96I82 | chr10: 101,061,841-101,068,131 |
KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
3812 | P43630 | chr19: 54,850,443-54,867,207 |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 | P10721 | chr4: 54,657,918-54,740,715 |
LAG3 | lymphocyte-activation gene 3 |
3902 | P18627 | chr12: 6,772,512-6,778,455 |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 |
3903 | Q6GTX8 | chr19: 54,351,384-54,370,558 |
LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 |
3904 | Q6ISS4 | chr19: 54,497,879-54,510,687 |
LEPR | leptin receptor |
3953 | P48357 | chr1: 65,420,652-65,641,559 |
LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
10859 | Q8NHL6 | chr19: 54,617,158-54,637,528 |
LINGO2 | leucine rich repeat and Ig domain containing 2 |
158038 | Q7L985 | chr9: 27,948,078-28,670,286 |
LRIG1 | leucine-rich repeats and immunoglobulin-like domains 1 |
26018 | Q96JA1 | chr3: 66,378,797-66,501,263 |
LRIG2 | leucine-rich repeats and immunoglobulin-like domains 2 |
9860 | O94898 | chr1: 113,073,209-113,132,260 |
LRIG3 | leucine-rich repeats and immunoglobulin-like domains 3 |
121227 | Q6UXM1 | chr12: 58,872,149-58,920,522 |
LRRN1 | leucine rich repeat neuronal 1 |
57633 | Q6UXK5 | chr3: 3,799,437-3,847,703 |
LRRN3 | leucine rich repeat neuronal 3 |
54674 | Q9H3W5 | chr7: 111,091,006-111,125,454 |
LSAMP | limbic system-associated membrane protein |
4045 | Q13449 | chr3: 115,802,363-117,139,389 |
LSR | lipolysis stimulated lipoprotein receptor |
51599 | Q86X29 | chr19: 35,248,330-35,267,964 |
MAG | myelin associated glycoprotein |
4099 | P20916 | chr19: 35,292,125-35,313,804 |
MCAM | melanoma cell adhesion molecule |
4162 | P43121 | chr11: 119,308,529-119,321,521 |
MERTK | MER proto-oncogene, tyrosine kinase |
10461 | Q12866 | chr2: 111,898,479-112,029,561 |
MFAP3 | microfibrillar associated protein 3 |
4238 | P55082 | chr5: 154,038,906-154,220,478 |
MFAP3L | microfibrillar associated protein 3 like |
9848 | O75121 | chr4: 169,986,597-170,033,031 |
MICA | MHC class I polypeptide-related sequence A |
100507436 | Q29983 | chr6: 31,399,784-31,415,315 |
MICB | MHC class I polypeptide-related sequence B |
4277 | Q29980 | chr6: 31,494,881-31,511,124 |
MPZL1 | myelin protein zero-like 1 |
9019 | O95297 | chr1: 167,721,192-167,791,919 |
MPZL2 | myelin protein zero-like 2 |
10205 | O60487 | chr11: 118,253,403-118,264,536 |
MR1 | major histocompatibility complex, class I-related |
3140 | Q95460 | chr1: 181,033,425-181,061,938 |
MUSK | muscle, skeletal, receptor tyrosine kinase |
4593 | O15146 | chr9: 110,668,771-110,801,620 |
MXRA5 | matrix-remodelling associated 5 |
25878 | Q9NR99 | chrX: 3,308,565-3,346,641 |
MYBPC1 | myosin binding protein C, slow type |
4604 | Q00872 | chr12: 101,568,353-101,686,018 |
MYLK | myosin light chain kinase |
4638 | Q15746 | chr3: 123,610,049-123,884,331 |
MYOT | myotilin |
9499 | Q9UBF9 | chr5: 137,867,791-137,887,851 |
NCAM1 | neural cell adhesion molecule 1 |
4684 | P13591 | chr11: 112,961,247-113,278,436 |
NCAM2 | neural cell adhesion molecule 2 |
4685 | O15394 | chr21: 20,998,315-21,543,329 |
NCAN | neurocan |
1463 | O14594 | chr19: 19,211,973-19,252,233 |
NECTIN1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) |
5818 | Q15223 | chr11: 119,623,408-119,729,084 |
NECTIN3 | poliovirus receptor-related 3 |
25945 | Q9NQS3 | chr3: 111,070,071-111,275,563 |
NEXN | nexilin (F actin binding protein) |
91624 | Q0ZGT2 | chr1: 77,888,513-77,943,895 |
NRCAM | neuronal cell adhesion molecule |
4897 | Q92823 | chr7: 108,147,623-108,456,717 |
NRG1 | neuregulin 1 |
3084 | Q02297 | chr8: 31,639,386-32,767,959 |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 |
4914 | P04629 | chr1: 156,815,640-156,881,850 |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
4915 | Q16620 | chr9: 84,668,551-85,027,070 |
OBSL1 | obscurin-like 1 |
23363 | O75147 | chr2: 219,550,729-219,571,859 |
PALLD | palladin, cytoskeletal associated protein |
23022 | Q8WX93 | chr4: 168,497,066-168,928,457 |
PAPLN | papilin, proteoglycan-like sulfated glycoprotein |
89932 | O95428 | chr14: 73,237,497-73,274,640 |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide |
5156 | P16234 | chr4: 54,229,097-54,298,247 |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide |
5159 | P09619 | chr5: 150,113,837-150,155,872 |
PECAM1 | platelet/endothelial cell adhesion molecule 1 |
5175 | P16284 | chr17: 64,319,415-64,413,776 |
PILRA | paired immunoglobin-like type 2 receptor alpha |
29992 | Q9UKJ1 | chr7: 100,367,530-100,400,099 |
PILRB | paired immunoglobin-like type 2 receptor beta |
29990 | Q9UKJ0 | chr7: 100,352,176-100,367,733 |
PSG3 | pregnancy specific beta-1-glycoprotein 3 |
5671 | Q16557 | chr19: 42,721,638-42,740,569 |
PSG7 | pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) |
5676 | Q13046 | chr19: 42,924,132-42,937,178 |
PTCRA | pre T-cell antigen receptor alpha |
171558 | Q6ISU1 | chr6: 42,915,989-42,925,835 |
PTK7 | protein tyrosine kinase 7 (inactive) |
5754 | Q13308 | chr6: 43,076,268-43,161,719 |
PTPRD | protein tyrosine phosphatase, receptor type, D |
5789 | P23468 | chr9: 8,314,246-10,612,723 |
PTPRF | protein tyrosine phosphatase, receptor type, F |
5792 | P10586 | chr1: 43,525,187-43,623,666 |
PTPRK | protein tyrosine phosphatase, receptor type, K |
5796 | Q15262 | chr6: 127,968,779-128,520,674 |
PTPRM | protein tyrosine phosphatase, receptor type, M |
5797 | P28827 | chr18: 7,566,782-8,406,861 |
PVR | poliovirus receptor |
5817 | P15151 | chr19: 44,643,798-44,663,583 |
ROBO2 | roundabout guidance receptor 2 |
6092 | Q9HCK4 | chr3: 75,906,695-77,649,964 |
ROBO3 | roundabout guidance receptor 3 |
64221 | Q96MS0 | chr11: 124,865,386-124,881,470 |
ROR1 | receptor tyrosine kinase-like orphan receptor 1 |
4919 | Q01973 | chr1: 63,774,022-64,181,498 |
SDK1 | sidekick cell adhesion molecule 1 |
221935 | Q7Z5N4 | chr7: 3,301,448-4,269,000 |
SDK2 | sidekick cell adhesion molecule 2 |
54549 | Q58EX2 | chr17: 73,334,384-73,644,089 |
SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
10371 | Q14563 | chr7: 83,955,777-84,492,724 |
SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
7869 | Q13214 | chr3: 50,267,558-50,277,546 |
SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
10512 | Q99985 | chr7: 80,742,538-80,922,359 |
SEMA3D | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
223117 | O95025 | chr7: 84,995,553-85,186,855 |
SEMA3E | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
9723 | O15041 | chr7: 83,363,906-83,649,010 |
SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) |
8482 | O75326 | chr15: 74,409,289-74,434,467 |
SIGIRR | single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
59307 | Q6IA17 | chr11: 405,716-417,455 |
SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin |
6614 | Q9BZZ2 | chr20: 3,686,970-3,707,128 |
SIGLEC11 | sialic acid binding Ig-like lectin 11 |
114132 | Q96RL6 | chr19: 49,948,985-49,961,172 |
SIGLEC7 | sialic acid binding Ig-like lectin 7 |
27036 | Q9Y286 | chr19: 51,142,299-51,153,526 |
SIRPA | signal-regulatory protein alpha |
140885 | P78324 | chr20: 1,894,167-1,940,592 |
SLAMF8 | SLAM family member 8 |
56833 | Q9P0V8 | chr1: 159,826,750-159,837,249 |
TAPBPL | TAP binding protein-like |
55080 | Q9BX59 | chr12: 6,451,690-6,466,517 |
TEK | TEK tyrosine kinase, endothelial |
7010 | Q02763 | chr9: 27,109,141-27,230,175 |
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
7075 | P35590 | chr1: 43,300,993-43,323,108 |
TREM1 | triggering receptor expressed on myeloid cells 1 |
54210 | Q9NP99 | chr6: 41,267,926-41,286,719 |
TTN | titin |
7273 | Q8WZ42 | chr2: 178,525,989-178,830,802 |
TYRO3 | TYRO3 protein tyrosine kinase |
7301 | Q06418 | chr15: 41,557,675-41,583,586 |
UNC5B | unc-5 netrin receptor B |
219699 | Q8IZJ1 | chr10: 71,212,570-71,302,864 |
UNC5C | unc-5 netrin receptor C |
8633 | O95185 | chr4: 95,162,504-95,549,206 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VCAN | versican |
1462 | P13611 | chr5: 83,471,465-83,582,303 |
VSIG2 | V-set and immunoglobulin domain containing 2 |
23584 | Q96IQ7 | chr11: 124,747,472-124,752,238 |
VSIG4 | V-set and immunoglobulin domain containing 4 |
11326 | Q9Y279 | chrX: 66,021,738-66,040,125 |
VSTM2L | V-set and transmembrane domain containing 2 like |
128434 | Q96N03 | chr20: 37,903,104-37,945,350 |
VSTM4 | V-set and transmembrane domain containing 4 |
196740 | Q8IW00 | chr10: 49,014,245-49,115,509 |
VTCN1 | V-set domain containing T cell activation inhibitor 1 |
79679 | Q7Z7D3 | chr1: 117,143,587-117,210,960 |